WEKO3
アイテム
{"_buckets": {"deposit": "a9caa98e-6a39-4d87-9c30-d6610069d51b"}, "_deposit": {"created_by": 1, "id": "46729", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "46729"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00046729", "sets": ["1"]}, "author_link": ["465958", "465962", "465966", "465967", "465970", "465960", "465964", "465965", "465968", "465961", "465959", "465969", "465963"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2013-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "5584", "bibliographicPageStart": "5579", "bibliographicVolumeNumber": "33", "bibliographic_titles": [{"bibliographic_title": "Anticancer research"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Aim: The purpose of this study was to evaluate the role of FDG-PET regarding the indication of preoperative carbon-ion radiotherapy (CIRT) for pancreatic cancer patients.\nPATIENTS AND METHODS: \nPatients with resectable pancreatic cancer underwent preoperative CIRT. The impact of baseline SUVmax on prognosis for patients was assessed by analyzing correlations with distant metastasis-free survival (DMFS) and overall survival (OS).\nRESULTS: \nOut of 21 patients, local recurrence was observed in no patient and distant metastasis was found in 13 patients (62%). 1-year DMFS and OS in low-SUVmax group were significantly higher than those in high-SUVmax group (91% vs. 20% and 91% vs. 56%). SUVmax was significantly correlated with DMFS and OS.\nCONCLUSION: \nOur data indicated a significant correlation between SUVmax and DMFS. FDG-PET might be useful for determining the indication of preoperative short-course CIRT for patients with resectable pancreatic cancer.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "International Institute of Anticancer Research"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "24324101", "subitem_relation_type_select": "PMID"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0250-7005", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Shinoto, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "465958", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "465959", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshikawa, Kyosan"}], "nameIdentifiers": [{"nameIdentifier": "465960", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yasuda, Shigeo"}], "nameIdentifiers": [{"nameIdentifier": "465961", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shioyama, Yoshiyuki"}], "nameIdentifiers": [{"nameIdentifier": "465962", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Honda, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "465963", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "465964", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "465965", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山田 滋", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "465966", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "吉川 京燦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "465967", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "安田 茂雄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "465968", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "465969", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "465970", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography as Predictor of Distant Metastasis in Preoperative Carbon-ion Radiotherapy for Pancreatic Cancer.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography as Predictor of Distant Metastasis in Preoperative Carbon-ion Radiotherapy for Pancreatic Cancer."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/46729", "pubdate": {"attribute_name": "公開日", "attribute_value": "2014-03-04"}, "publish_date": "2014-03-04", "publish_status": "0", "recid": "46729", "relation": {}, "relation_version_is_last": true, "title": ["Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography as Predictor of Distant Metastasis in Preoperative Carbon-ion Radiotherapy for Pancreatic Cancer."], "weko_shared_id": -1}
Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography as Predictor of Distant Metastasis in Preoperative Carbon-ion Radiotherapy for Pancreatic Cancer.
https://repo.qst.go.jp/records/46729
https://repo.qst.go.jp/records/46729fd83840b-a8f7-4421-be4f-63be1df078d7
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-03-04 | |||||
タイトル | ||||||
タイトル | Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography as Predictor of Distant Metastasis in Preoperative Carbon-ion Radiotherapy for Pancreatic Cancer. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Shinoto, Makoto
× Shinoto, Makoto× Yamada, Shigeru× Yoshikawa, Kyosan× Yasuda, Shigeo× Shioyama, Yoshiyuki× Honda, Hiroshi× Kamada, Tadashi× Tsujii, Hirohiko× 山田 滋× 吉川 京燦× 安田 茂雄× 鎌田 正× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Aim: The purpose of this study was to evaluate the role of FDG-PET regarding the indication of preoperative carbon-ion radiotherapy (CIRT) for pancreatic cancer patients. PATIENTS AND METHODS: Patients with resectable pancreatic cancer underwent preoperative CIRT. The impact of baseline SUVmax on prognosis for patients was assessed by analyzing correlations with distant metastasis-free survival (DMFS) and overall survival (OS). RESULTS: Out of 21 patients, local recurrence was observed in no patient and distant metastasis was found in 13 patients (62%). 1-year DMFS and OS in low-SUVmax group were significantly higher than those in high-SUVmax group (91% vs. 20% and 91% vs. 56%). SUVmax was significantly correlated with DMFS and OS. CONCLUSION: Our data indicated a significant correlation between SUVmax and DMFS. FDG-PET might be useful for determining the indication of preoperative short-course CIRT for patients with resectable pancreatic cancer. |
|||||
書誌情報 |
Anticancer research 巻 33, 号 12, p. 5579-5584, 発行日 2013-12 |
|||||
出版者 | ||||||
出版者 | International Institute of Anticancer Research | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0250-7005 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 24324101 |